Search

everythinglearnresearchcommunity

for

Search:↓

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

A woman with severe angioedema improved significantly after treatment with rituximab.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Psychotropic medications can cause skin problems but also treat some skin conditions.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

People with atopic dermatitis have a higher risk of developing autoimmune diseases.

COVID-19 can cause or worsen skin issues.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Mnemonics help improve memory in dermatology by up to 50%.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

A fungus ball in the lung can cause coughing up blood in SLE patients.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.